↓ Skip to main content

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma

Overview of attention for article published in Hematology Transfusion and Cell Therapy, November 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma
Published in
Hematology Transfusion and Cell Therapy, November 2021
DOI 10.1016/j.htct.2021.09.003
Pubmed ID
Authors

Alvaro J. Alencar, Alexandre V. Hirayama, Diego V. Clé, Marco Aurélio Salvino, Guilherme Perini, Celso Arrais, Otávio Baiocchi, Leonardo Carvalho Palma, Iago Colturato, Jorge Vaz, Ricardo Chiattone, Marcos de Lima, Jayr Schmidt Filho, Samir Nabhan, Vanderson Rocha, Renato L. Guerino-Cunha, Carlos S. Chiattone

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 21%
Student > Ph. D. Student 4 12%
Student > Master 3 9%
Other 2 6%
Student > Postgraduate 2 6%
Other 3 9%
Unknown 12 36%
Readers by discipline Count As %
Medicine and Dentistry 9 27%
Nursing and Health Professions 4 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Chemical Engineering 1 3%
Other 3 9%
Unknown 12 36%